Skip to content
Search

Latest Stories

India's frontline doctors 'fearful for their lives'

India's frontline doctors 'fearful for their lives'

LOW PAY, 24-hour shifts and severe shortages of staff and protective gear have left many doctors on the frontlines of India's brutal pandemic surge near breaking point and fearful for their lives.

Coronavirus infections have killed at least 165,000 people in the vast South Asian nation -- home to some of the world's most densely populated cities -- since the start of April.


Although India's latest Covid-19 surge has eased recently, around 3,000 people are still dying every day and the chronically underfunded health care system remains under severe pressure.

"We are overworked, stressed and very frightened," Radha Jain, a doctor in the capital New Delhi, told AFP.

The Indian Medical Association said more than 1,200 doctors have died of Covid since the start of the pandemic -- including over 500 in the last two months.

Deependra Garg, a doctor working in Delhi's outskirts, knows first-hand how dire the situation has become.

His wife Anubha, 48, a physician herself, fell ill with Covid in April.

They started treatment at home but as her condition worsened, he -- like so many other families -- struggled to get a hospital bed.

He eventually found one almost 200 kilometres (120 miles) from their home. But Anubha -- who was fully vaccinated -- died within two weeks, leaving behind their 12-year-old daughter.

"We are on the frontlines 24/7. We are exposed to a high virus load but we have to continue working against all odds as we have chosen this profession," Garg said.

"We do not have a choice."

Structural weaknesses in healthcare 

The pandemic has exposed structural weaknesses in India's healthcare system, particularly in the ill-equipped state-run hospitals.

As the latest outbreak spread, reports emerged from short-staffed hospitals of patients lying on floors and sharing beds in packed wards, as family members protected with only cotton masks took care of their stricken loved ones.

The government spends less than two per cent of GDP on healthcare, one of the lowest rates in the world.

India had just 0.8 doctors per 1,000 people in 2017 -- around the same level as Iraq, according to the World Bank. The two other countries worst-hit by the coronavirus, Brazil and the US, had 2.2 and 2.6 respectively.

A report from before the pandemic by the US-based Center for Disease Dynamics, Economics and Policy estimated that India needed 600,000 more doctors and two million extra nurses to meet its healthcare needs.

Doctor Shekhar Kumar, working with a private hospital in the northern state of Uttar Pradesh, said junior staff and final-year medical students sometimes had to work 24-hour shifts.

"Compared to last year, this time patients are needing longer hospital stays which is increasing the burden on the staff," Kumar said.

He added that they were further stretched when their colleagues fell ill with the virus.

Doctors said they had been traumatised by being forced to choose which patients to save first as they grappled with insufficient supplies of medicine and oxygen.

Ravikant Singh, the founder of a charity group helping to set up Covid field hospitals, said he struggled to sleep some nights.

Even after completing their punishing shifts, doctors said they worried about infecting their families at home.

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less